Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (10045)	11/18/2008 7:04:47 PM
From: Arthur Radley	Read Replies (1) of 10345

NEW YORK, Nov 18 (Reuters) - Elan Corp Plc (ELN.N: Quote, Profile, Research, Stock Buzz) (ELN.I: Quote, Profile, Research, Stock Buzz) aims to cut costs, close locations and raise up to $500 million through licensing deals as it seeks to strengthen its balance sheet and offset slower growth of its multiple sclerosis drug Tysabri. reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next